Publications

2013 cardiometabolic

Device factors affecting pulmonary delivery of dry powders.

Ther. Deliv.

2013; 4(8): 939-49

2012 cardiometabolic

Technosphere Insulin Effectively Controls Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus.

Diabetes Technol. Ther.

2012;14: 9‍97-1‍001

2012 cardiometabolic

The V-Go Insulin Delivery Device Used in Clinical Practice: Patient Perception and Retrospective Analysis of Glycemic Control

Endocr Pract.

2012; 18(5): 660-67

2012 cardiometabolic

Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: A randomized trial.

Diabetes Obesity Metab.

2012; 14: 163-173.

2011 cardiometabolic

Insulin Lung Deposition and Clearance Following Technosphere^® Insulin Inhalation Powder Administration

Pharm. Res.

2011; 28; 2‍157–2‍164

2008 cardiometabolic

A Delineation of Diketopiperazine Self-Assembly Processes: Understanding the Molecular Events Involved in N^ϵ-(Fumaroyl) diketopiperazine of l-Lys (FDKP) Interactions.

Mol. Pharmaceutics.

2008; 5(2): 294–315

2008 cardiometabolic

Basal—Prandial Insulin Delivery in Type 2 Diabetes Mellitus via the V-Go™: A Novel Continuous Subcutaneous Infusion Device

J Diabetes Sci Technol.

2008; 2(1): 40-46

2007 cardiometabolic

Coverage of Postprandial Blood Glucose Excursions With Inhaled Technosphere Insulin in Comparison to Subcutaneously Injected Regular Human Insulin in Subjects With Type 2 Diabetes.

Diabetes Care

2007; 30(9):2307-8

2007 cardiometabolic

Technosphere insulin technology.

Diabetes Technol. Ther.

2007; 9 Suppl 1: S65-72

2005 cardiometabolic

Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism.

Expert Opinion Drug Delivery.

2005; 2(6): 1097-106.

2002 cardiometabolic

Technosphere/Insulin – a New Approach for Effective Delivery of Human Insulin via the Pulmonary Route

Diabetes Technol. Ther.

2002; 4(5): 589-94

2002 cardiometabolic

Technosphere/Insulin–proof of concept study with a new insulin formulation for pulmonary delivery.

Exp. Clin. Endocrinol. Diabetes

2002; 110(1): 17-21